Patents by Inventor Malin Marie Lindstedt

Malin Marie Lindstedt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell line and uses thereof
    Patent number: 11815509
    Abstract: The present invention provides a non-naturally occurring dendritic-like myeloid leukaemia cell according to ATCC Patent Deposit Designation PTA-123875, and methods and kits utilising such cells.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: November 14, 2023
    Assignee: SENZAGEN AB
    Inventors: Malin Marie Lindstedt, Carl A K Borrebaeck, Henrik Johansson, Robin Gradin
  • NOVEL CELL LINE AND USES THEREOF
    Publication number: 20220178913
    Abstract: The present invention provides a non-naturally occurring dendritic-like myeloid leukaemia cell according to ATCC Patent Deposit Designation PTA-123875, and methods and kits utilising such cells.
    Type: Application
    Filed: September 24, 2018
    Publication date: June 9, 2022
    Inventors: Malin Marie Lindstedt, Carl A K Borrebaeck, Henrik Johansson, Robin Gradin
  • Analytical methods and arrays for use in the same
    Patent number: 11324787
    Abstract: The present invention relates to a method for identifying the skin sensitizer potency of a test agent, and arrays and analytical kits for use in such methods.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: May 10, 2022
    Assignee: SENZAGEN AB
    Inventors: Malin Marie Lindstedt, Carl A. K. Borrebaeck, Henrik Johansson, Ann-Sofie Albrekt, Kathrin Stephanie Zeller, Aakash Chawade, Tim Carl Sewe Lindberg, Andy Andreas Sebastian Forreryd
  • ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
    Publication number: 20200115741
    Abstract: The present invention relates to a method for identifying proteins which are allergenic in a mammal, and arrays and analytical kits for use in such methods.
    Type: Application
    Filed: April 23, 2018
    Publication date: April 16, 2020
    Inventors: Malin Marie Lindstedt, Henrik Johansson, Kathrin Zeller Walther
  • ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
    Publication number: 20190083556
    Abstract: The present invention relates to a method for identifying the skin sensitizer potency of a test agent, and arrays and analytical kits for use in such methods.
    Type: Application
    Filed: March 22, 2017
    Publication date: March 21, 2019
    Applicant: SENZAGEN AB
    Inventors: Malin Marie Lindstedt, Carl A.K. Borrebaeck, Henrik Johansson, Ann-Sofie Albrekt, Kathrin Stephanie Zeller, Aakash Chawade, Tim Carl Sewe Lindberg, Andy Andreas Sebastian Forreryd
  • Compositions comprising polyglutamic acid nanoparticles and CD40 agonists
    Patent number: 9486520
    Abstract: The present invention provides pharmaceutical compositions comprising an immunostimulatory polypeptide and polyglutamic acid (PGA) nanoparticles, formulated in a pharmaceutically acceptable diluent, carrier or excipient. Such compositions have utility in stimulating the immune system in subjects, with the components capable of interacting synergistically. The invention further provides uses of the compositions of the invention, for example in the treatment of cancer, and kit and components for use in the same.
    Type: Grant
    Filed: April 13, 2011
    Date of Patent: November 8, 2016
    Assignee: Alligator Bioscience AB
    Inventors: Carl Arne Krister Borrebaeck, Sissela Rachel Linn Broos, Peter Bo Joakim Ellmark, Malin Marie Lindstedt
  • COMPOSITIONS COMPRISING POLYGLUTAMIC ACID NANOPARTICLES AND POLYPEPTIDES SUCH AS CD40 AGONISTS
    Publication number: 20130028932
    Abstract: The present invention provides pharmaceutical compositions comprising an immunostimulatory polypeptide and polyglutamic acid (PGA) nanoparticles, formulated in a pharmaceutically acceptable diluent, carrier or excipient. Such compositions have utility in stimulating the immune system in subjects, with the components capable of interacting synergistically. The invention further provides uses of the compositions of the invention, for example in the treatment of cancer, and kit and components for use in the same.
    Type: Application
    Filed: April 13, 2011
    Publication date: January 31, 2013
    Applicant: Alligator Bioscience AB
    Inventors: Carl Arne Krister Borrebaeck, Sissela Rachel Linn Broos, Peter Bo Joakim Ellmark, Malin Marie Lindstedt